… practical review of the current standard of care for these diseases, including IgM monoclonal gammopathies of clinical … (in bone marrow, and in some studies in peripheral blood) Standard first line therapy in transplant eligible …

… EBMT risk score (AUC 0.70 vs. 0.65). Arai et al. (Blood Advances, 2019) also used an alternating decision tree … reasons, among them are new cancers and cardiovascular diseases. 44% of patients are not adherent to health care …

… particularly, long-term toxicity and the risk of secondary diseases remain major concerns. Marion Rougé then presented a … in 1966 for people with neutropenia or undergoing blood cancer treatment.  There is a lack of evidence and …